Are you Dr. Smalley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
20375 W 151st St
Olathe, KS 66061Phone+1 913-768-7200Fax+1 913-768-9712
Summary
- Dr. Stephen Smalley, MD is a radiation oncologist in Olathe, Kansas. He is currently licensed to practice medicine in Kansas and Missouri. He is affiliated with Olathe Medical Center, AdventHealth Shawnee Mission, and Providence Medical Center.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1984 - 1986
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1982 - 1984
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1979 - 1982
- University of Missouri Kansas City School of MedicineClass of 1979
Certifications & Licensure
- KS State Medical License 1987 - 2024
- MO State Medical License 1994 - 2020
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
- Join now to see all
Clinical Trials
- SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Start of enrollment: 1994 Mar 01
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum Start of enrollment: 2004 Aug 01
Publications & Presentations
PubMed
- 18 citationsCetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713Cynthia G. Leichman, Shannon McDonough, Stephen R. Smalley, Kevin G. Billingsley, Heinz-Josef Lenz
Clinical Colorectal Cancer. 2017-10-24 - 9 citationsPharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and RadiationPierre Oliver Bohanes, Cathryn Rankin, Charles D. Blanke, Thomas Winder, Cornelia M. Ulrich
Clinical Cancer Research. 2015-04-01 - 12 citationsPolymorphisms in folate‐metabolizing enzymes and response to 5‐fluorouracil among patients with stage II or III rectal cancer (INT‐0144; SWOG 9304)Cornelia M. Ulrich, Cathryn Rankin, Adetunji T. Toriola, Karen W. Makar, Özge Altug-Teber
Cancer. 2014-11-01
Professional Memberships
- Member